Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Paediatrics, College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Blood Adv. 2019 Jul 23;3(14):2118-2127. doi: 10.1182/bloodadvances.2018029546.
FOXO1 has an oncogenic role in adult germinal center-derived lymphomas, in which mutations, predominately within the AKT recognition motif, cause nuclear retention of FOXO1, resulting in increased cell proliferation. To determine the prevalence and distribution of mutations in pediatric Burkitt lymphoma (BL), we sequenced a large number of sporadic and endemic BL patient samples. We report a high frequency of mutations in both sporadic and endemic BL at diagnosis, occurring in 23/78 (29%) and 48/89 (54%) samples, respectively, as well as 8/16 (50%) cases at relapse. Mutations of T24 were the most common in sporadic BL but were rare in endemic cases, in which mutations of residue S22, also within the AKT recognition motif, were the most frequent. mutations were almost always present in the major tumor cell clone but were not associated with outcome. Analysis of other recurrent mutations reported in BL revealed that mutations were associated with mutations of and but not , / or members of the phosphatidylinositol 3-kinase signaling pathway. We further show common nuclear retention of the FOXO1 protein, irrespective of mutation status, suggesting alternative unknown mechanisms for maintaining FOXO1 transcriptional activity in BL. CRISPR/Cas9 knockout of in an endemic cell line produced a significant decrease in cell proliferation, supporting an oncogenic role for in endemic BL. Thus, is frequently mutated in both sporadic and endemic BL and may offer a potential therapeutic target for pediatric BL patients worldwide.
FOXO1 在成人生发中心衍生的淋巴瘤中具有致癌作用,其中突变主要发生在 AKT 识别基序内,导致 FOXO1 的核内滞留,从而导致细胞增殖增加。为了确定儿童伯基特淋巴瘤(BL)中突变的流行率和分布,我们对大量散发性和地方性 BL 患者样本进行了测序。我们报告了在散发性和地方性 BL 诊断时 突变的高频发生,分别在 23/78(29%)和 48/89(54%)样本中,以及在 8/16(50%)复发病例中。T24 突变在散发性 BL 中最为常见,但在地方性病例中很少见,在 AKT 识别基序内的 S22 残基突变最为常见。 突变几乎总是存在于主要肿瘤细胞克隆中,但与结局无关。对 BL 中报道的其他反复发生的突变的分析表明, 突变与 和 突变有关,但与 、 或磷脂酰肌醇 3-激酶信号通路的成员无关。我们进一步表明,无论突变状态如何,FOXO1 蛋白的常见核内滞留提示 BL 中维持 FOXO1 转录活性的替代未知机制。CRISPR/Cas9 敲除地方性细胞系中的 会导致细胞增殖显著减少,支持 在地方性 BL 中的致癌作用。因此, 在散发性和地方性 BL 中经常发生突变,可能为全球儿童 BL 患者提供潜在的治疗靶点。